Terms: = Lymphoma AND MYH11, ENSG00000133392, 4629 AND Treatment
21 results:
1. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
Liu Y; Klein J; Bajpai R; Dong L; Tran Q; Kolekar P; Smith JL; Ries RE; Huang BJ; Wang YC; Alonzo TA; Tian L; Mulder HL; Shaw TI; Ma J; Walsh MP; Song G; Westover T; Autry RJ; Gout AM; Wheeler DA; Wan S; Wu G; Yang JJ; Evans WE; Loh M; Easton J; Zhang J; Klco JM; Meshinchi S; Brown PA; Pruett-Miller SM; Ma X
Nat Commun; 2023 Apr; 14(1):1739. PubMed ID: 37019972
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of Helicobater pylori eradication in patients with diffuse large B-cell lymphoma of the stomach: A systematic review.
De Francesco V; Manta R; Marmo R; Marmo C; Rago A; Antonelli G; Hassan C; Zullo A
Eur J Haematol; 2022 Dec; 109(6):643-647. PubMed ID: 36175387
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic of Core Binding Factor (CBF) Acute Myeloid Leukemia With Complex Karyotype.
Marcault C; Boissel N; Haferlach C; Loschi M; Raynaud S; Cluzeau T
Clin Lymphoma Myeloma Leuk; 2022 Mar; 22(3):e199-e205. PubMed ID: 34674982
[TBL] [Abstract] [Full Text] [Related]
4. The clinical mutatome of core binding factor leukemia.
Opatz S; Bamopoulos SA; Metzeler KH; Herold T; Ksienzyk B; Bräundl K; Tschuri S; Vosberg S; Konstandin NP; Wang C; Hartmann L; Graf A; Krebs S; Blum H; Schneider S; Thiede C; Middeke JM; Stölzel F; Röllig C; Schetelig J; Ehninger G; Krämer A; Braess J; Görlich D; Sauerland MC; Berdel WE; Wörmann BJ; Hiddemann W; Spiekermann K; Bohlander SK; Greif PA
Leukemia; 2020 Jun; 34(6):1553-1562. PubMed ID: 31896782
[TBL] [Abstract] [Full Text] [Related]
5. ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation.
Yang X; Shi J; Zhang X; Zhang G; Zhang J; Yang S; Wang J; Ke X; Fu L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31028135
[TBL] [Abstract] [Full Text] [Related]
6. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
[TBL] [Abstract] [Full Text] [Related]
7. Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing Clinician.
Hantel A; Stock W; Kosuri S
Clin Lymphoma Myeloma Leuk; 2018 Oct; 18(10):636-647. PubMed ID: 30006258
[TBL] [Abstract] [Full Text] [Related]
8. Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia.
Matsuo H; Iijima-Yamashita Y; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
Pediatr Int; 2018 Jan; 60(1):41-46. PubMed ID: 29067751
[TBL] [Abstract] [Full Text] [Related]
9. Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction.
Cunningham L; Finckbeiner S; Hyde RK; Southall N; Marugan J; Yedavalli VR; Dehdashti SJ; Reinhold WC; Alemu L; Zhao L; Yeh JR; Sood R; Pommier Y; Austin CP; Jeang KT; Zheng W; Liu P
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14592-7. PubMed ID: 22912405
[TBL] [Abstract] [Full Text] [Related]
10. [Large sample clinical analysis of patients with children acute leukemia in single center].
Zeng HM; Guo Y; Yi XL; Zhou JF; An WB; Zhu XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):692-5. PubMed ID: 21729552
[TBL] [Abstract] [Full Text] [Related]
11. Common leukemia- and lymphoma-associated genetic aberrations in healthy individuals.
Song J; Mercer D; Hu X; Liu H; Li MM
J Mol Diagn; 2011 Mar; 13(2):213-9. PubMed ID: 21354057
[TBL] [Abstract] [Full Text] [Related]
12. [Genotyping and minimal residual disease study in children with acute myeloid leukemia: preliminary results].
Balwierz W; Pietrzyk JJ; Wator G; Stozek K; Klekawka T; Kwiecińska K; Dłuzniewska A; Matysiak M; Malinowska I; Sikorska-Fic B; Balcerska A; Maciejka-Kapuścińska L; Sońta-Jakimczyk D; Tomaszewska R; Chybicka A; Krawczuk-Rybak M; Muszyńska-Rosłan K; Młynarski W; Stolarska M; Urasiński T; Kamieńska E; Sobol G; Wieczorek M; Karolczyk G; Wysocki M; Kołtan S; Kowalczyk JR; Wójcik B; Ksiazek T; Szewczyk K
Przegl Lek; 2010; 67(6):371-4. PubMed ID: 21344764
[TBL] [Abstract] [Full Text] [Related]
13. Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma.
Basecke J; Podleschny M; Becker A; Seiffert E; Schwiers I; Schwiers R; Haase D; Glass B; Schmitz N; Trumper L; Griesinger F
Br J Haematol; 2008 Apr; 141(1):52-9. PubMed ID: 18324966
[TBL] [Abstract] [Full Text] [Related]
14. A >or=1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor acute myeloid leukemia and predicts subsequent morphologic relapse.
Lane S; Saal R; Mollee P; Jones M; Grigg A; Taylor K; Seymour J; Kennedy G; Williams B; Grimmett K; Griffiths V; Gill D; Hourigan M; Marlton P
Leuk Lymphoma; 2008 Mar; 49(3):517-23. PubMed ID: 18297529
[TBL] [Abstract] [Full Text] [Related]
15. Acute leukemia: subtype discovery and prediction of outcome by gene expression profiling.
Downing JR
Verh Dtsch Ges Pathol; 2003; 87():66-71. PubMed ID: 16888896
[TBL] [Abstract] [Full Text] [Related]
16. Multiplex real-time RT-PCR for prospective evaluation of WT1 and fusion gene transcripts in newly diagnosed de novo acute myeloid leukemia.
Yanada M; Terakura S; Yokozawa T; Yamamoto K; Kiyoi H; Emi N; Kitamura K; Kohno A; Tanaka M; Tobita T; Takeo T; Sao H; Kataoka T; Kobayashi M; Takeshita A; Morishita Y; Naoe T; Sugiura I
Leuk Lymphoma; 2004 Sep; 45(9):1803-8. PubMed ID: 15223639
[TBL] [Abstract] [Full Text] [Related]
17. [Detection of core-binding factor in acute leukemia with interphase fluorescence in situ hybridization].
Liu XL; Du QF; Song LL; Zhang S; Li R; Lin R; Liu QF; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1038-41. PubMed ID: 14559688
[TBL] [Abstract] [Full Text] [Related]
18. Primary aleukemic myeloid leukemia cutis treated successfully with combination chemotherapy: report of a case and review of the literature.
Chang H; Shih LY; Kuo TT
Ann Hematol; 2003 Jul; 82(7):435-9. PubMed ID: 12768324
[TBL] [Abstract] [Full Text] [Related]
19. Assessment of minimal residual disease (MRD) in CBFbeta/myh11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.
Guerrasio A; Pilatrino C; De Micheli D; Cilloni D; Serra A; Gottardi E; Parziale A; Marmont F; Diverio D; Divona M; Lo Coco F; Saglio G
Leukemia; 2002 Jun; 16(6):1176-81. PubMed ID: 12040450
[TBL] [Abstract] [Full Text] [Related]
20. Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/myh11 RT-PCR: implications for a monitoring schedule and for treatment decisions.
Laczika K; Mitterbauer G; Mitterbauer M; Knöbl P; Schwarzinger I; Greinix HT; Rabitsch W; Fonatsch C; Mannhalter C; Lechner K; Jaeger U
Leuk Lymphoma; 2001; 42(5):923-31. PubMed ID: 11697647
[TBL] [Abstract] [Full Text] [Related]
[Next]
